Get 20% lifetime commission for referring investors to digrin.com
here.
Voyager Therapeutics, Inc. ( VYGR) - Key Metrics
VYGR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | -$0.40 | -$0.43 | -$0.43 |
| 2026Q1 | $0.04 | -$0.47 | -$0.56 | -$0.56 |
| 2025Q4 | $0.26 | -$0.47 | -$0.52 | -$0.53 |
| 2025Q3 | $0.23 | -$0.47 | -$0.53 | -$0.53 |
| 2025Q2 | $0.09 | -$0.57 | -$0.57 | -$0.59 |
VYGR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.19 |
| 2026Q1 | 0% | -2.05 |
| 2025Q4 | 0% | -2.09 |
| 2025Q3 | 0% | -2.48 |
| 2025Q2 | 0% | -1.36 |
VYGR
Price: $1.90
52 week price:
Earnings Per Share: -1.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275000
Ebitda: -22.9 millionMarket Capitalization: 148.6 million